Interference of Apoptosis by Hepatitis B Virus
Hepatitis B virus (HBV) causes liver diseases that have been a consistent problem for human health, leading to more than one million deaths every year worldwide. A large proportion of hepatocellular carcinoma (HCC) cases across the world are closely associated with chronic HBV infection. Apoptosis i...
| Published in: | Viruses |
|---|---|
| Main Authors: | Shaoli Lin, Yan-Jin Zhang |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2017-08-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/9/8/230 |
Similar Items
Hepatitis B virus X protein accelerates the development of hepatoma
by: Xiao-Dong Zhang, et al.
Published: (2014-09-01)
by: Xiao-Dong Zhang, et al.
Published: (2014-09-01)
Persistence of Hepatitis B Virus Infection: A Multi-Faceted Player for Hepatocarcinogenesis
by: Suchandrima Ghosh, et al.
Published: (2021-08-01)
by: Suchandrima Ghosh, et al.
Published: (2021-08-01)
Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma
by: Yaqin Zhang, et al.
Published: (2024-12-01)
by: Yaqin Zhang, et al.
Published: (2024-12-01)
Modern views on the role of <i>X</i> gene of the hepatitis B virus (<i>Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus</i>) in the pathogenesis of the infection it causes
by: Y. V. Panasiuk, et al.
Published: (2022-03-01)
by: Y. V. Panasiuk, et al.
Published: (2022-03-01)
Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do
by: Walaa Abdelhamed, et al.
Published: (2024-06-01)
by: Walaa Abdelhamed, et al.
Published: (2024-06-01)
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
by: Marc Ringelhan, et al.
Published: (2024-10-01)
by: Marc Ringelhan, et al.
Published: (2024-10-01)
Hepatocellular carcinoma patients with undetectable baseline hepatitis B viral DNA may benefit from immunotherapy
by: Yan Jian, et al.
Published: (2025-07-01)
by: Yan Jian, et al.
Published: (2025-07-01)
Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma
by: Ruonan Sun, et al.
Published: (2023-04-01)
by: Ruonan Sun, et al.
Published: (2023-04-01)
Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes
by: Lei Wang, et al.
Published: (2022-12-01)
by: Lei Wang, et al.
Published: (2022-12-01)
The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review
by: Shang‐Chin Huang, et al.
Published: (2024-01-01)
by: Shang‐Chin Huang, et al.
Published: (2024-01-01)
Hepatitis B Virus Integration into Transcriptionally Active Loci and HBV-Associated Hepatocellular Carcinoma
by: Maria Bousali, et al.
Published: (2022-01-01)
by: Maria Bousali, et al.
Published: (2022-01-01)
Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B
by: Shang-Chin Huang, et al.
Published: (2022-11-01)
by: Shang-Chin Huang, et al.
Published: (2022-11-01)
GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients
by: Clemens Schotten, et al.
Published: (2021-07-01)
by: Clemens Schotten, et al.
Published: (2021-07-01)
Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma
by: Selena Y. Lin, et al.
Published: (2021-05-01)
by: Selena Y. Lin, et al.
Published: (2021-05-01)
Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma
by: Mingxue Yu, et al.
Published: (2021-03-01)
by: Mingxue Yu, et al.
Published: (2021-03-01)
Hepatitis B virus integration and hepatocarcinogenesis
by: Linlin Ma, et al.
Published: (2025-09-01)
by: Linlin Ma, et al.
Published: (2025-09-01)
Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes
by: Pranav P. Mathkar, et al.
Published: (2021-02-01)
by: Pranav P. Mathkar, et al.
Published: (2021-02-01)
Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma
Published: (2007-12-01)
Published: (2007-12-01)
The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates
by: Agustiningsih Agustiningsih, et al.
Published: (2024-02-01)
by: Agustiningsih Agustiningsih, et al.
Published: (2024-02-01)
Effects of hypersplenism on the outcome of hepatectomy in hepatocellular carcinoma with hepatitis B virus related portal hypertension
by: Xiao Chen, et al.
Published: (2023-03-01)
by: Xiao Chen, et al.
Published: (2023-03-01)
Silicon Nanowire Field-Effect Transistor as Label-Free Detection of Hepatitis B Virus Proteins with Opposite Net Charges
by: Suh Kuan Yong, et al.
Published: (2021-11-01)
by: Suh Kuan Yong, et al.
Published: (2021-11-01)
Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases
by: Xin Miao, et al.
Published: (2024-04-01)
by: Xin Miao, et al.
Published: (2024-04-01)
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment
by: F. D’Andrea, et al.
Published: (2020-03-01)
by: F. D’Andrea, et al.
Published: (2020-03-01)
KIF20A activated by transcription factor GATA2 promotes cell growth in hepatitis B virus-related hepatocellular carcinoma
by: Juan Xu, et al.
Published: (2024-11-01)
by: Juan Xu, et al.
Published: (2024-11-01)
Management of Chronic Hepatitis B in HIV-Coinfected Patients
by: Massimo Fasano, et al.
Published: (2022-09-01)
by: Massimo Fasano, et al.
Published: (2022-09-01)
Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence
by: Thomas Tu, et al.
Published: (2021-01-01)
by: Thomas Tu, et al.
Published: (2021-01-01)
Accelerating Decreases in the Incidences of Hepatocellular Carcinoma at a Younger Age in Shanghai Are Associated With Hepatitis B Virus Vaccination
by: Shunzhang Yu, et al.
Published: (2022-04-01)
by: Shunzhang Yu, et al.
Published: (2022-04-01)
Perspectives and control of hepatitis B virus infection in Taiwan
by: Chih-Lin Lin, et al.
Published: (2015-10-01)
by: Chih-Lin Lin, et al.
Published: (2015-10-01)
Hepatitis B Virus-X Downregulates Expression of Selenium Binding Protein 1
by: Young-Man Lee, et al.
Published: (2020-05-01)
by: Young-Man Lee, et al.
Published: (2020-05-01)
Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC
by: Wanting Shi, et al.
Published: (2023-11-01)
by: Wanting Shi, et al.
Published: (2023-11-01)
Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
by: Madison Force, et al.
Published: (2022-04-01)
by: Madison Force, et al.
Published: (2022-04-01)
The Hepatitis B Virus PreS1/HBsAg Ratio Is a Predictive Marker for the Occurrence of Hepatocellular Carcinoma
by: Masanari Kosaka, et al.
Published: (2024-08-01)
by: Masanari Kosaka, et al.
Published: (2024-08-01)
Links between human LINE-1 retrotransposons and hepatitis virus-related hepatocellular carcinoma
by: Tomoyuki eHonda, et al.
Published: (2016-05-01)
by: Tomoyuki eHonda, et al.
Published: (2016-05-01)
The Adaptive Immune Response in Hepatitis B Virus-Associated Hepatocellular Carcinoma Is Characterized by Dysfunctional and Exhausted HBV-Specific T Cells
by: Malene Broholm, et al.
Published: (2024-04-01)
by: Malene Broholm, et al.
Published: (2024-04-01)
Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells
by: Yuanyuan Ji, et al.
Published: (2018-05-01)
by: Yuanyuan Ji, et al.
Published: (2018-05-01)
MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS B
by: I. P. Balmasova, et al.
Published: (2016-04-01)
by: I. P. Balmasova, et al.
Published: (2016-04-01)
Mechanisms of hepatitis B virus X protein in progression and drug resistance of hepatocellular carcinoma
by: Zhou Ping, et al.
Published: (2025-06-01)
by: Zhou Ping, et al.
Published: (2025-06-01)
ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
by: Siyou Tan, et al.
Published: (2022-03-01)
by: Siyou Tan, et al.
Published: (2022-03-01)
Inhibition of Hepatitis B Virus (HBV) replication and antigen expression by Brucea javanica (L.) Merr. oil emulsion
by: Bo Qin, et al.
Published: (2023-07-01)
by: Bo Qin, et al.
Published: (2023-07-01)
Epitranscriptomic Regulation of Hepatitis B Virus by RNA 5-Methylcytosine: Functions, Mechanisms, and Therapeutic Potential
by: Xuliu Zhou, et al.
Published: (2025-08-01)
by: Xuliu Zhou, et al.
Published: (2025-08-01)
Similar Items
-
Hepatitis B virus X protein accelerates the development of hepatoma
by: Xiao-Dong Zhang, et al.
Published: (2014-09-01) -
Persistence of Hepatitis B Virus Infection: A Multi-Faceted Player for Hepatocarcinogenesis
by: Suchandrima Ghosh, et al.
Published: (2021-08-01) -
Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma
by: Yaqin Zhang, et al.
Published: (2024-12-01) -
Modern views on the role of <i>X</i> gene of the hepatitis B virus (<i>Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus</i>) in the pathogenesis of the infection it causes
by: Y. V. Panasiuk, et al.
Published: (2022-03-01) -
Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do
by: Walaa Abdelhamed, et al.
Published: (2024-06-01)
